Table 2 Treatment characteristics of study participants
Characteristic | Regular medical care | Coagulation service |
|---|---|---|
Total amount of treatment days | 4,681,125 | 931,579 |
Total amount of international normalized ratio (INR) values | 29,748 | 19,207 |
Median time between INR measurements [days; interquartile range] | 17.0 (10.7/26.0) | 15.2 (11.4/18.8) |
Self-management of oral anticoagulant therapy | 13.5 (271) | 9.5 (72) |
Physician in charge | ||
General practitioner, % (no.) | 67.6 (1,359) | n.a.* |
Specialist, % (no.) | 32.3 (650) | n.a.* |
Home visits, % (no.) | 6.8 (137) | 8.8 (67) |
Vitamin K antagonist in use | ||
Warfarin, % (no.) | 1.7 (34) | 1.7 (13) |
Phenprocoumon, % (no.) | 98.3 (1,977) | 98.3 (747) |